$OKUR
OnKure Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
OnKure Therapeutics, Inc. Class A Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $2.40 at 09:31 AM on Nov 06, then ran to $2.88 +20% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is OKUR down today? It is at $2.70 (-2.17%), and our scanner flagged it 38 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OKUR spikes, and full due diligence on OKUR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OKUR 38 times in the last 30 days. Create a free account to track $OKUR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how OKUR traded in the last session, Friday (last price and move above). Our scanner fired 7 unusual-volume and momentum alerts on OKUR on Friday, peaking at 34.9x its normal volume.
Likely catalystOnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business HighlightsReported Cash position: As of September 30, 2026, the Company reported cash, cash equivalents, and marketable securities of $163.3 million, which is expected to provide cash runway into 2029.Reported Net loss and net loss per share were $17.8 million, or $0.36 per share, for the third quarter of 2026, compared to $14.7 million, or $1.09 per share, for the third quarter of 2025., from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedNov 20, 2026 · yesterdayA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent share offering + active shelf on file — the company raised capital and can raise more
About $100.0M in size
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Leverone Jason A. Officer | Sold (automatic/other) | -302 | sold 1.6% | 19K | $897 at $2.97 | Sep 21, 26 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -87 | sold 0.8% | 11K | $258 at $2.97 | Sep 21, 26 |
Leverone Jason A. Officer | Sold (automatic/other) | -303 | sold 1.6% | 19K | $1K at $4.40 | Jun 22, 26 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -86 | sold 0.8% | 11K | $378 at $4.40 | Jun 22, 26 |
Leverone Jason A. Officer | Sold (automatic/other) | -301 | sold 1.8% | 16K | $1K at $4.16 | Mar 23, 26 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -86 | sold 1.2% | 7K | $358 at $4.16 | Mar 23, 26 |
Manke Isaac Director | Acquired (grant/award) | +5K 0.01% of company | added 34% | 21K | n/a | Dec 31, 25 |
Mathers Edward T Director | Acquired (grant/award) | +4K | added 34% | 15K | n/a | Dec 31, 25 |
Leverone Jason A. Officer | Sold (automatic/other) | -302 | sold 1.8% | 16K | $897 at $2.97 | Dec 22, 25 |
Saccomano Nicholas A Officer | Sold (automatic/other) | -87 | sold 1.2% | 7K | $258 at $2.97 | Dec 22, 25 |
Manke Isaac Director | Acquired (grant/award) | +6K 0.01% of company | added 57% | 15K | n/a | Sep 30, 25 |
Mathers Edward T Director | Acquired (grant/award) | +4K 0.01% of company | added 57% | 11K | n/a | Sep 30, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how OKUR traded in the last session, Friday (last price and move above). Our scanner fired 7 unusual-volume and momentum alerts on OKUR on Friday, peaking at 34.9x its normal volume.
OKUR last traded at $2.70, down 2.17% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The OKUR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OKUR 38 times in the last 30 days.
OKUR (OnKure Therapeutics, Inc. Class A Common Stock) trades on XNAS, with a market cap of about $109M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OKUR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OKUR discussion
Sign in to ask a question or join the discussion.